Sana Biotechnology (SANA) Capital Expenditures (2020 - 2026)
Sana Biotechnology recorded quarterly Capital Expenditures of $288000.0 in Q1 2026, down 67.01% quarter-over-quarter from $873000.0 in Q4 2025, and up 111.76% year-over-year from $136000.0 in Q1 2025.
Sana Biotechnology's Capital Expenditures history runs 7 years deep, the most recent figure standing at $288000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 111.76% year-over-year to $288000.0; the TTM figure through Mar 2026 stood at $1.1 million (up 106.94% YoY), while the FY2025 annual figure was $938000.0, changed N/A from the prior year.
- Capital Expenditures came in at $288000.0 for Q1 2026 at Sana Biotechnology, down from $873000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $15.8 million in Q1 2024 to a low of -$12.5 million in Q2 2024.
- A 5-year average of $1.9 million and a median of $873000.0 in 2025 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 1536.88% in 2024 and fell as far as 1365.89% in 2024.
- Sana Biotechnology's Capital Expenditures stood at $4.6 million in 2022, then slumped by 110.04% to -$462000.0 in 2023, then soared by 44.16% to -$258000.0 in 2024, then jumped by 438.37% to $873000.0 in 2025, then plunged by 67.01% to $288000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $288000.0, $873000.0, and $65000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Sana Biotechnology | 890.09 Mn | 890.09 Mn | - | 288,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288,000.00 |
| Mar 31, 2026 | 288,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | -136,000.00 |
| Jun 30, 2025 | -136,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Dec 31, 2024 | -258,000.00 |
| Dec 31, 2024 | -258,000.00 |
| Sep 30, 2024 | -3.12 Mn |
| Sep 30, 2024 | -3.12 Mn |
| Jun 30, 2024 | -12.47 Mn |
| Jun 30, 2024 | -12.47 Mn |
| Mar 31, 2024 | 15.85 Mn |
| Mar 31, 2024 | 15.85 Mn |
| Dec 31, 2023 | -462,000.00 |
| Dec 31, 2023 | -462,000.00 |
| Sep 30, 2023 | 7.98 Mn |
| Sep 30, 2023 | 7.98 Mn |
| Jun 30, 2023 | 985,000.00 |
| Jun 30, 2023 | 985,000.00 |
| Mar 31, 2023 | 968,000.00 |
| Mar 31, 2023 | 968,000.00 |
| Dec 31, 2022 | 4.60 Mn |
| Dec 31, 2022 | 4.60 Mn |
| Sep 30, 2022 | 4.35 Mn |
| Sep 30, 2022 | 4.35 Mn |
| Jun 30, 2022 | 8.50 Mn |
| Jun 30, 2022 | 8.50 Mn |
| Mar 31, 2022 | 3.43 Mn |
| Mar 31, 2022 | 3.43 Mn |
| Dec 31, 2021 | -21.65 Mn |
| Dec 31, 2021 | -21.65 Mn |
| Sep 30, 2021 | 8.06 Mn |
| Sep 30, 2021 | 8.06 Mn |
| Jun 30, 2021 | 13.44 Mn |
| Jun 30, 2021 | 13.44 Mn |
| Mar 31, 2021 | 3.16 Mn |
| Mar 31, 2021 | 3.16 Mn |
| Dec 31, 2020 | 9.27 Mn |
| Dec 31, 2020 | 9.27 Mn |
| Sep 30, 2020 | 6.32 Mn |
| Sep 30, 2020 | 6.32 Mn |
| Jun 30, 2020 | 2.69 Mn |
| Jun 30, 2020 | 2.69 Mn |
| Mar 31, 2020 | 5.60 Mn |
| Mar 31, 2020 | 5.60 Mn |